Diamine compound for resisting hepatitis B virus and its preparation method and its application

An amine compound and anti-hepatitis B technology, which is applied in the anti-hepatitis B virus diamine compound and its preparation and application field, can solve the problems of low glycyrrhizin content, complicated extraction and separation process, difficult quality control, etc., to achieve inhibition of hepatitis B virus, Simple synthetic route and low preparation cost

CN1962615AInactive Publication Date: 2007-05-16TIANJIN UNIV
1 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CN · China
Current Assignee / Owner
Publication Date
2007-05-16
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention discloses a diamine compound of anti-hepatitis B virus and preparing method and application with structure as formula (I), which is characterized by the following: adopting compound in the structural formula (II) as raw material; oxidizing directly; fitting for preparing the drug to prevent or treat relative disease of anti-hepatitis B virus.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention relates to a preparation method and application of a class of anti-hepatitis B virus diamine compound, which belongs to the anti-hepatitis B virus compound and its synthesis method and application. Background technique

[0002] Hepatitis B surface antigen, referred to as HBsAg, exists in the outer shell of hepatitis B virus. The detection of HBsAg in serum is one of the early diagnostic indicators of hepatitis B. After hepatitis B virus infection, most people have no clinical manifestations, but HBsAg can be detected in the blood. These people are usually called HBsAg carriers. Hepatitis B e antigen, referred to as HBeAg for short, is the soluble component of HBcAg. HBeAg is associated with the virus Dane particles and hepatitis B virus DNA, and is a serological indicator of active hepatitis B virus replication. Positive serum HBeAg indicates strong infectivity. After the liver cells are invaded by the hepatitis B virus, the hepatitis B...

Examples

Embodiment 1

[0057] Example 1: Preparation of (Z)-N-phenyl-N-(2-N', N'-dimethyloxyaminomethyl-3-phenylallyl)acetamide;

[0058] Take 20mL ethanol, weigh 0.500g (E)-N-phenyl-N-(2-N', N'-dimethylaminomethyl-3-phenylallyl) acetamide, add to 50mL round bottom In the flask, add 0.789g of 28% hydrogen peroxide to the above mixture, react at room temperature for 10 days, remove the solvent under reduced pressure, and vacuum dry to obtain (Z)-N-phenyl-N-(2-N', N'- Dimethyloxyaminomethyl-3-phenylallyl)acetamide 0.499g, yield 95%. IR (KBr, cm -1 ): 2952, 2861, 1662, 1494, 1389, 699; 1 HNMR (CDCl 3 , ppm.): 1.88 (s, 3H), 2.53 (s, 6H), 4.28 (d, 2H), 5.12 (d, 2H), 7.02-7.43 (m, 10H), 8.02 (s, 1H).

Embodiment 2

[0059] Example 2: (Z)-N-(2-methoxyphenyl)-N-(2-N', N'-dimethyloxyaminomethyl-3-phenylallyl)acetamide preparation of

[0060] Take 20mL ethanol, weigh 0.500g (E)-N-(2-methoxyphenyl)-N-(2-N', N'-dimethylaminomethyl-3-phenylallyl) ethyl Add amide into a 50mL round bottom flask, add 0.718g28% hydrogen peroxide to the above mixture, react at room temperature for 10 days, remove the solvent under reduced pressure, and vacuum dry to obtain (Z)-N-(2-methoxybenzene Base)-N-(2-N',N'-dimethyloxyaminomethyl-3-phenylallyl)acetamide 0.492g, yield 94%. IR (KBr, cm -1 ): 2953, 2847, 1662, 1499, 1389, 752; 1 HNMR (CDCl 3 , ppm.): 1.84(s, 3H), 2.51(s, 6H), 3.715(s, 3H), 4.21-4.32(m, 2H), 4.99-5.13(m, 2H), 7.00-7.38(m, 9H), 7.91 (s, 1H).

Embodiment 3

[0061] Example 3: Preparation of (Z)-N-(4-fluorophenyl)-N-(2-N', N'-dimethyloxyaminomethyl-3-phenylallyl)acetamide ;

[0062] Take 20mL of ethanol, weigh 0.500g of (E)-N-(4-fluorophenyl)-N-(2-N',N'-dimethylaminomethyl-3-phenylallyl)acetamide, Add it into a 50mL round bottom flask, add 0.745g of 28% hydrogen peroxide to the above mixture, react at room temperature for 10 days, remove the solvent under reduced pressure, and vacuum dry to obtain (Z)-N-(4-fluorophenyl)-N -(2-N', N'-dimethyloxyaminomethyl-3-phenylallyl)acetamide 0.477g, yield 91%. IR (KBr, cm -1 ): 2956, 2863, 1639, 1508, 1383, 704; 1 HNMR (CDCl 3 , ppm.): 1.85(s, 3H), 2.54(s, 6H), 4.21-4.32(m, 2H), 4.97-5.17(m, 2H), 6.70(s, 1H), 7.02-7.43(m, 9H).